550 related articles for article (PubMed ID: 22336380)
1. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades.
Epstein JI; Feng Z; Trock BJ; Pierorazio PM
Eur Urol; 2012 May; 61(5):1019-24. PubMed ID: 22336380
[TBL] [Abstract][Full Text] [Related]
2. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ
Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432
[TBL] [Abstract][Full Text] [Related]
3. Downgrading of biopsy based Gleason score in prostatectomy specimens.
Treurniet KM; Trudel D; Sykes J; Evans AJ; Finelli A; Van der Kwast TH
J Clin Pathol; 2014 Apr; 67(4):313-8. PubMed ID: 24403214
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of "regression to the mean" using routine clinical features with correlating biochemical relapse rates.
Altok M; Troncoso P; Achim MF; Matin SF; Gonzalez GN; Davis JW
Asian J Androl; 2019; 21(6):598-604. PubMed ID: 31115364
[TBL] [Abstract][Full Text] [Related]
5. [Clinically predictive factors of Gleason score upgrading in patients after radical prostatectomy].
Zuo Q; Zhang F; Huang Y; Ma LL; Lu M; Lu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):603-606. PubMed ID: 29263497
[TBL] [Abstract][Full Text] [Related]
6. The Discrepancy between Needle Biopsy and Radical Prostatectomy Gleason Score in Patients with Prostate Cancer.
Abedi AR; Basiri A; Shakhssalim N; Sadri G; Ahadi M; Hojjati SA; Sheykhzadeh S; Askarpour S; Ghiasy S
Urol J; 2020 Aug; 18(4):395-399. PubMed ID: 32798231
[TBL] [Abstract][Full Text] [Related]
7. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS
BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
[TBL] [Abstract][Full Text] [Related]
8. Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.
Huang CC; Kong MX; Zhou M; Rosenkrantz AB; Taneja SS; Melamed J; Deng FM
Am J Surg Pathol; 2014 Aug; 38(8):1096-101. PubMed ID: 24832163
[TBL] [Abstract][Full Text] [Related]
9. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
[TBL] [Abstract][Full Text] [Related]
10. Elevated fatty acid synthase expression in prostate needle biopsy cores predicts upgraded Gleason score in radical prostatectomy specimens.
Hamada S; Horiguchi A; Kuroda K; Ito K; Asano T; Miyai K; Iwaya K
Prostate; 2014 Jan; 74(1):90-6. PubMed ID: 24108439
[TBL] [Abstract][Full Text] [Related]
11. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
12. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
King CR; McNeal JE; Gill H; Presti JC
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
[TBL] [Abstract][Full Text] [Related]
13. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
[TBL] [Abstract][Full Text] [Related]
14. PI-RADS version 2 for prediction of pathological downgrading after radical prostatectomy: a preliminary study in patients with biopsy-proven Gleason Score 7 (3+4) prostate cancer.
Woo S; Kim SY; Lee J; Kim SH; Cho JY
Eur Radiol; 2016 Oct; 26(10):3580-7. PubMed ID: 26847042
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of downgrading and upgrading from biopsy to radical prostatectomy among men with Gleason score 7 prostate cancer.
Jang WS; Koh DH; Kim J; Lee JS; Chung DY; Ham WS; Rha KH; Choi YD
Prostate; 2019 Dec; 79(16):1805-1810. PubMed ID: 31483062
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
17. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.
Freedland SJ; Kane CJ; Amling CL; Aronson WJ; Terris MK; Presti JC;
Urology; 2007 Mar; 69(3):495-9. PubMed ID: 17382152
[TBL] [Abstract][Full Text] [Related]
18. Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation.
He B; Chen R; Gao X; Ren S; Yang B; Hou J; Wang L; Yang Q; Zhou T; Zhao L; Xu C; Sun Y
Oncotarget; 2016 Mar; 7(13):17275-85. PubMed ID: 26943768
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Preoperative and Radical Prostatectomy Gleason Score: Examining the Predictors of Upgrade and Downgrade Results.
Pourmand G; Gooran S; Hossieni SR; Guitynavard F; Safavi M; Sharifi A; Mokhtari E
Acta Med Iran; 2017 Apr; 55(4):249-253. PubMed ID: 28532136
[TBL] [Abstract][Full Text] [Related]
20. Adverse Disease Features in Gleason Score 3 + 4 "Favorable Intermediate-Risk" Prostate Cancer: Implications for Active Surveillance.
Morlacco A; Cheville JC; Rangel LJ; Gearman DJ; Karnes RJ
Eur Urol; 2017 Sep; 72(3):442-447. PubMed ID: 27574819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
